CytoTools

Latest

CytoTools: DPOLC also effective against influenza viruses

According to the company, CytoTool’s active ingredient DPOLC has shown positive results in test series for its effectiveness on influenza…

Read More »
Latest

Cytotools: tension before the general meeting

In India, Cytotools has its first revenue with DermaPro. A phase III study has started in Europe. The pandemic creates…

Read More »
Latest

CytoTools now produces DermaPro active ingredient DPOLC in Saarbrücken

CytoTools can now produce the active ingredient DPOLC, which is used in the skin drug DermaPro, among other things, at…

Read More »
Latest

CytoTools share: COVID-19 news causes price jump – the details

On Friday morning there is a significant price jump in the CytoTools share. This is currently quoted in XETRA trading…

Read More »
Latest

Cytotools: New CFO and EUR 6 million for development

Cytotools announces the appointment of a Chief Financial Officer. Marc Herwick will hold the newly created position on the board…

Read More »
Latest

CytoTools: Centaur starts marketing DermaPro in India

CytoTools announces the start of the marketing of the wound healing drug DermaPro in India. Marketing partner Centaur Pharmaceuticals will…

Read More »
Latest

CytoTools: Black numbers from 2023

A product for the treatment of diabetic foot syndrome and open leg is expected to be launched in India soon.…

Read More »
Latest

CytoTools: Patent-News brings share price jump

A clear price gain can be observed today for the CytoTools share. In XETRA trading on the Frankfurt Stock Exchange,…

Read More »
Back to top button
Close
Close